TSX News -
Theratechnologies Announces New Positive Results for two Investigational Peptide-Drug Conjugates Targeting Sortilin Positive Ovarian Cancer
TH1902 and TH1904 more effective and safer in vivo compared to current standard ovarian cancer treatmentsNew data presented during the […]